Similar articles

• Progression of Barrett's esophagus to adenocarcinoma despite antireflux surgery.

  von Conrady D, Smith MJ, Khan MF, Tan S, Mortimer G, McAnena OJ. von Conrady D, et al. Endoscopy. 2008 Sep;40 Suppl 2:E68-9. doi: 10.1055/s-2007-995507. Epub 2008 Feb 26. Endoscopy. 2008. PMID: 18633915 No abstract available.
• [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].

  Incarbone R, Bonavina L, Bassi F, Peracchia A. Incarbone R, et al. Chir Ital. 2002 Sep-Oct;54(5):591-6. Chir Ital. 2002. PMID: 12469454 Italian.
• Barrett's esophagus: a retrospective analysis of 13 years surveillance.

  Switzer-Taylor V, Schlup M, Lübcke R, Livingstone V, Schultz M. Switzer-Taylor V, et al. J Gastroenterol Hepatol. 2008 Sep;23(9):1362-7. doi: 10.1111/j.1440-1746.2008.05311.x. Epub 2008 Jan 17. J Gastroenterol Hepatol. 2008. PMID: 18205769
• Treatment of Barrett's esophagus with high-grade dysplasia.

  McAllaster JD, Buckles D, Al-Kasspooles M. McAllaster JD, et al. Expert Rev Anticancer Ther. 2009 Mar;9(3):303-16. doi: 10.1586/14737140.9.3.303. Expert Rev Anticancer Ther. 2009. PMID: 19275509 Review.
• New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy.

  DeMeester SR. DeMeester SR. Ann Thorac Surg. 2008 Feb;85(2):S747-50. doi: 10.1016/j.athoracsur.2007.10.102. Ann Thorac Surg. 2008. PMID: 18222209 Review. No abstract available.